QUIT
Achieve Life Sciences, Inc.
There isn't enough reported data to score QUIT yet.
QUIT Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
QUIT's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.
QUIT PE Valuation
QUIT has no meaningful PE right now: it lost money over the past year.
QUIT Forward outlook
There aren't enough analyst estimates for QUIT to show an outlook.
QUIT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$1.33 | +$0.06 |
| Q2 2026 | -$1.50 | -$0.03 |
| Q1 2026 | -$1.07 | +$0.28 |
| Q4 2025 | -$1.25 | -$0.01 |
| Q3 2025 | -$1.39 | -$0.29 |
| Q2 2025 | -$1.47 | -$0.39 |
| Q1 2025 | -$1.35 | -$0.09 |
| Q4 2024 | -$1.24 | +$0.26 |
QUIT is still losing money, but far less than before: $1.33 per share over the past year, against $42.60 at its worst in late 2019.
QUIT Quarterly Revenue
QUIT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$8.4M | +$2.9M |
| Q1 2026 | -$6.9M | +$4.2M |
| Q2 2025 | -$9.1M | -$4.1M |
| Q1 2025 | -$11.1M | -$5.8M |
| Q2 2024 | -$4.9M | +$1.8M |
| Q1 2024 | -$5.3M | +$3M |
| Q4 2023 | -$4.4M | +$6.8M |
| Q2 2023 | -$6.7M | +$1.6M |
QUIT has burned cash in almost every quarter: −$45M over the past year, against −$30M the year before.
QUIT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +13% | +12M shares |
| 1 year | +204% | +70.8M shares |
| 3 years | +489% | +87.6M shares |
| 5 years | +3107% | +102M shares |
QUIT has 105M diluted shares, up 204% from a year ago.
QUIT Net Leverage
QUIT's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
QUIT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.5 | Neutral |
| Stochastic | 20.7 | Neutral |
QUIT's weekly RSI is 49 (neutral) and its Stochastic is 21 (neutral).
QUIT PE vs Healthcare Sector
QUIT has no meaningful PE right now: it lost money over the past year.
QUIT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $6.86 | 8.3% below |
| 20 week MA | $7.00 | 10% below |
| 50 week MA | $5.58 | 13% above |
| 100 week MA | $4.36 | 44% above |
| 200 week MA | $4.68 | 34% above |
QUIT has slipped below its 8- and 20-week averages, though it's still 34% above its 200-week average.
QUIT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $10.8 | $7.98 | -26% |
| 2021 | $7.98 | $7.87 | -1.4% |
| 2022 | $7.87 | $2.50 | -68% |
| 2023 | $2.50 | $4.12 | +65% |
| 2024 | $4.12 | $3.64 | -12% |
| 2025 | $3.64 | $4.49 | +23% |
| 2026 YTD | $4.49 | $6.29 | +40% |
QUIT is up 40% so far in 2026, after finishing lower in four of the previous six years.